The DNA replication inhibitor microcin B17 is a peptide antibiotic produced by Escherichia coli strains carrying plasmid pMccBl7. Here we present evidence that antibiotic activities previously named colicin X are probably identical to microcin B17. Our results include comparison of the conditions of production of the antibiotics, their mode of action, cross-immunity of producer strains, and cross-resistance of resistant mutants. Plasmids encoding colicin X have been identified and shown to have a region of significant homology with the microcin B17-producing region of pMccBl7 DNA.
plates. Kmr clones were isolated twice on LB plates supplemented with the antibiotic and then checked for colicin production. The standard sensitive indicator strain used throughout was E. coli K-12 strain BZB1011. We found that the ability to produce the antibiotic could be transferred by conjugation from the strain producing colicin X-W7 but not from the strain producing colicin X-CA23. Plasmid DNA from strain II17/CA23a2 was then extracted and used to transform CaCl2-treated BZB1011 cells. Transformants were selected in minimal M63-glucose medium supplemented with microcin B17 as previously described (16) . Approximately 40% of the colonies growing in this medium were colicin X producers, and the others were microcin B17-resistant mutants.
Transconjugant clones producing colicin X-W7 and transformed clones producing colicin X-CA23 were then examined for their plasmid content. The first group had acquired a unique plasmid species of about 75 kb, and the second * Corresponding author. (8) , and pMccC7 (43 kb) (10) as molecular weight markers. These size estimates were confirmed by digestions with BamHI, EcoRI, and SalI restriction endonucleases (data not shown). We concluded that the production of colicins X-W7 and X-CA23 is determined by plasmids of 75 to 80 kb (pColX-W7) and 55 to 60 kb (pColX-CA23), respectively.
In subsequent conjugations we transferred the capacity to produce colicin X-W7 to several E. coli K-12 strains; this was always associated with the presence of pColX-W7. In contrast, we were unable to detect conjugal transfer of pColX-CA23 to any host even after selecting for colicin X or microcin B17 immunity. However, plasmid pColX-CA23 could be introduced by transformation into these different hosts, where it was stably maintained. Since strain II17/CA23a2 received the ability to produce this colicin from the wild-type strain CA23 by conjugation (P. Fredericq, personal communication), it can be concluded that either the frequency of conjugative transfer of pColX-CA23 is very low or the plasmid we have detected is a nonconjugative derivative of the original pColX-CA23. It is also possible that the original strain harbored another plasmid that mobilized pColX-CA23.
To compare microcin B17 and colicin X activities we used isogenic BZB1011 strains carrying plasmids pMccB17, pColX-W7, or pColX-CA23. The three strains showed crossimmunity, as we expected. We also observed that colicin X activity was indistinguishable from microcin B17 activity. For example, both passed through cellophane membranes (molecular weight cutoff, 10,000), were not inducible by mitomicin C, and inhibited DNA synthesis. In addition, RecA-and RecBC-cells were 8 to 10 times more sensitive than wild-type cells to both antibiotics.
E. coli K-12 mutants that were resistant or tolerant to microcin B17 were also resistant or tolerant to both colicins X. Microcin B17 resistance mutations map in a gene, sbmA, located at 8.7 min on the E. coli chromosome, closely linked to phoA (9) . Presumably, the rcx locus defined by mutations to colicin X resistance and located between 7.8 and 13.3 min on the E. coli chromosome (4) is the same as sbmA. Mutants tolerant to microcin B17 map in two loci, ompF and ompR, which affect production of the outer membrane porin protein OmpF and result in reduced sensitivity to a number of other agents (colicins, bacteriophages, etc.) besides microcin B17 (9) . Colicin X-tolerant mutants of phenotypic classes Tol Colicin X factor received from E. coli CA23.
b Colicin X factor received from E. coli W7.
XIV and Tol XV, selected by Davies and Reeves, had mutations that mapped in the ompR locus (4, 14) . The above data strongly indicated that colicin X and microcin B17 are similar or identical. To confirm this we investigated whether plasmids pColX-CA23 and pColX-W7 shared a region of significant homology with pMccBl7. The three plasmid DNAs were obtained from BZB1011 hosts by cesium chloride-ethidium bromide equilibrium centrifugation. They were then digested with BamHI, EcoRI, and both endonucleases together. The three plasmids contain a 5.2-kb BamHI-to-EcoRI fragment (Fig. 1A) . A fragment of this size is known to contain the microcin B17 production region and most of the microcin B17 immunity region in pMccBl7 (16 (17) .
hybridized with 32P-labeled pMM102, a pBR322 derivative containing the 5.2-kb BamHI-to-EcoRI fragment from pMccB17 (16) (Fig. 1B) . It is evident that the samne size fragment from the colicin X plasmids gives as strong a signal as that from pMccB17, indicating that the three fragments are highly homologous. Plasmid pMM102 also hybridized with a fragment of 6.7 kb from pColX-CA23 (Fig. 1B) . In Fig. 1A it is apparent that this fragment stained less with ethidium bromide than surrounding bands. One possibility is that it is an incomplete digestion product. We do not think that this is the case, because the same size fragment always appeared, even after extensive overdigestion with both restriction endonucleases. An alternative explanation is that a subpopulation of the pColX-CA23 plasmid preparation used contains a restriction fragment-length polymorphism. Further support for homology among the 5.2-kb BamHIEcoRI fragmnents of the three plasmids was obtained by digesting plasmid DNAs with the restriction endonuclease KpnI. Every plasmid yielded a fragment of 1.85 kb, which is known to be included in this BamHI-EcoRI fragment from pMccB17 (16) .
To get more information about the colicin X plasmids we determined whether they were incompatible with pMccB17. First, plasmids pMccBl7, pColX-W7, and pColX-CA23 were introduced into strain RYC819 Strr RecA-. All plasmids were stably maintained. The ability of pMccB17 to eliminate the other plasmids was then checked by introducing in the above hosts plasmid pMM22, a pMccB17 Mccderivative described elsewhere (16) The presence of DNA encoding microcin B17 (colicin X) on three different plasmids raised the possibility that the microcin B17-colicin X determinants are, or once were, located on a transposable DNA element. However, restriction data suggest that the three plasmids yielded a SalI fragment of 5.3 kb which is known to contain part of the information required for pMccB17 replication (F. Moreno, unpublished observations). In addition, when pColX-CA23 and pColX-W7 fragments were probed with 32P-labeled pMccB17 extensive areas of homology were observed (data not shown). Thus, the present information does not allow us to say whether the microcin B17-colicin X sequences are transposable.
Microcins display several properties which distinguish them from most colicins. With the exception of microcin A1S, which appears to be a derivative of the amino acid L-methionine (1), all of the microcins so far described are small peptides with molecular weights ranging from 500 to 5,000. Synthesis of microcins is not inducible by conditions or agents that activate the SOS repair system, and, at least in the case of microcin B17 and C7, several genes seem to be involved in microcin synthesis (3) . These characteristics contrast with those of most colicins, which range in size from 27,000 to 80,000 daltons and whose synthesis is SOS inducible. In all cases studied, a single structural gene is involved in synthesis of the active colicin (7) . The exceptions to this classification of colicins are colicin X, here shown to be the same as microcin B17, and colicin V. Colicin V is a small peptide, having a molecular weight of about 4,000, and its synthesis is not inducible. On the basis of these properties it has been recently suggested that colicin V might be more closely related to the microcins (18) . Colicin V, however, does not appear to be similar to any of the microcins described to date.
